Replies to post #1018 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

I’d rather there be less insider selling, of course; however, I don’t think the wording in the footnote of the CFO’s Form-4 is a big deal—i.e. it’s not something that would tip my decision to buy, sell, or hold to a material degree.